Press Releases 2009
-
Nov 10, 2009
:
SYGNIS reports on second quarter 2009/2010
-
Oct 19, 2009
:
SYGNIS secures up to € 10 Million through a 3 year Standby Equity Distribution Agreement (SEDA) with Yorkville
-
Sep 07, 2009
:
SYGNIS to present at the 11th Rodman & Renshaw Annual Global Investment Conference
-
Aug 12, 2009
:
SYGNIS advances development of AX200 in Q1 2009/2010
-
Jun 29, 2009
:
SYGNIS makes further progress in the 2008/2009 fiscal year
-
May 05, 2009
:
SYGNIS starts Phase II efficacy trial of AX200 for the treatment of acute ischemic stroke
-
Mar 24, 2009
:
SYGNIS granted key US patent on AX200 for the treatment of stroke patients
-
Feb 12, 2009
:
SYGNIS announces Q3 results
-
Jan 27, 2009
:
Mandatory offer of dievini Hopp BioTech holding GmbH & Co. KG completed
-
Jan 14, 2009
:
SYGNIS set to build on 2008 achievements to create further growth in 2009
-
Jan 07, 2009
:
SYGNIS-Boards recommend shareholders not to accept the mandatory offer of dievini Hopp BioTech holding GmbH & Co. KG